In this context, SPP1+ macrophages emerge as key immunosuppressive actors during glioma progression, being implicated in tumour progression and invasion, partly through their association with extracellular matrix remodelling factors like cathepsins, shaping an immunosuppressive tumour microenvironment, and correlating with decreased overall survival. This evidence concerns the gene SPP1 and glioma.